Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 06/30/26
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It LooksThe Motley Fool • 06/23/26
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor TherapiesZacks Investment Research • 06/18/26
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic HypersomniaPRNewsWire • 06/16/26
Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung CancerPRNewsWire • 06/12/26
Jazz Pharmaceuticals' New Cancer Drug Drives $1.3 Billion Opportunity, Says AnalystBenzinga • 06/10/26
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic HypersomniaPRNewsWire • 06/04/26
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/03/26
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum StockZacks Investment Research • 06/01/26
Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEAPRNewsWire • 05/27/26
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA TranscriptSeeking Alpha • 05/27/26
UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point24/7 Wall Street • 05/19/26
Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/19/26
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?Zacks Investment Research • 05/13/26
Jazz Pharmaceuticals Q1 Review: The Oncology Pivot Is Real, And The Market Is Still Mispricing ItSeeking Alpha • 05/06/26
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/06/26
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Top EstimatesZacks Investment Research • 05/05/26